MDClone
PrivateLast Round
Series C
Mar 1, 2022
Total Funding Raised
$104M
Company Overview
MDClone operates in Healthcare & Life Sciences and is based in Israel. Its latest recorded funding round was a Series C round in March 2022.
MDClone is a healthcare technology company that provides a self-service data analytics platform for healthcare organizations to securely access, explore, and analyze medical data using synthetic data generation.
Sector
Healthcare & Life Sciences
Verticals
Synthetic Data, Healthcare Analytics, Data Governance, NLP & Conversational AI
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MDClone Comparables
Compare MDClone with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| KPMG | 72% | |
| Rhino Health, Inc. | 72% | |
| MOSTLY.AI | 71% |
For institutional investors. Book with your work email.
MDClone Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Mar 1, 2022 | ||||
| Series B | Aug 22, 2019 | ||||
| Series A | Feb 5, 2018 | ||||
| Seed | Jan 1, 2016 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
MDClone Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| OrbiMed | Series B, Series C, Series A, Seed |
| aMoon | Series C, Series B |
| Warburg Pincus | Series C |
| Viola Growth | Series C |
| Lightspeed Venture Partners | Series B, Series C, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 5, 2026
Launched ADAMS Copilot, a generative AI healthcare data assistant.
- Oct 28, 2025
Sponsored and attended the HIMSS Eastern Canada Chapter's 2025 Digital Health Innovation Conference.
For institutional investors. Book with your work email.
MDClone Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about MDClone's valuation, stock price, and market status.
Is MDClone a public or private company?
MDClone is a private company.
What is the current stock price of MDClone?
MDClone is a private company, so its shares have no public market price. Caplight tracks MDClone's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is MDClone worth (valuation)?
Valuation information for MDClone is not publicly available.
Can I buy MDClone stock?
MDClone shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was MDClone's last funding round?
MDClone's most recent funding round was Series C on March 1, 2022.
Who are the main investors in MDClone?
Key investors in MDClone include OrbiMed, aMoon, Warburg Pincus, Viola Growth, Lightspeed Venture Partners.
Will MDClone IPO soon?
No public IPO plans have been announced for MDClone.
How can I track MDClone secondary market activity?
Caplight tracks bids, offers, and trades in MDClone's shares on secondary markets.